Gabapentin Generics: Pfizer’s Greenstone Captures 23% Of Market
This article was originally published in The Pink Sheet Daily
Executive Summary
As of Oct. 12, Teva held a 45.5% generic gabapentin share based on sales to large purchasers while Alpharma held 23.5% and Greenstone 23%, Teva says in court filings. Teva’s customers include CVS and McKesson; Greenstone is selling to Cardinal, Caremark and Medco.